31 May 2023
SHARE NOW
ATW
Cell Therapy
Gene Therapy
GMP
This Presentation from Advanced Therapies Week 2023 focusses on a new offering from Charles River for expediting plasmid DNA production and supply, the eXpDNATM platform.
During this session, Ramin Baghirzade, Senior Director, Gene Therapy at Charles River Laboratories begins by briefly introducing Charles River’s CDMO Solutions, before presenting on the current demand or need for plasmid DNA within the advanced therapies industry.
Ramin then unveils the eXpDNATM plasmid platform, before summarizing the session.
This Presentation was presented at Advanced Therapies Week 2023, in partnership with Charles River.
More like this
Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment
Taysha is discontinuing the development of TSHA-120 in GAN following the Type C meeting feedback from the FDA
21 September 2023
Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux
Oxford Biomedica in Exclusive Talks to Acquire ABL Europe from Institut Mérieux.
20 September 2023
The Cell & Gene Therapy Manufacturing Capacity Map
The only live, interactive manufacturing capacity compendium for the advanced therapies industry.
20 September 2023
